This cookie is set by GDPR Cookie Consent plugin. The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". The cookie is used to store the user consent for the cookies in the category "Analytics".
Set by the GDPR Cookie Consent plugin, this cookie is used to record the user consent for the cookies in the "Advertisement" category. These cookies ensure basic functionalities and security features of the website, anonymously. Necessary cookies are absolutely essential for the website to function properly. Muriel Vray has coordinated the methodology of several multicenter therapeutic trials on HIV and viral hepatitis in France, Africa and Asia for the ANRS and Pasteur Institute and is carrying out epidemiological studies in the field of chronic diseases. She is an expert advisor to several regulatory commissions: AFSSAPS (Marketing Authorization, Working group on HIV and viral hepatitis), HAS (High Authority of Health, Working group on the evaluation of the impact of treatment on public health), ANRS (French Agency on HIV and the viral hepatitis) and both participates in and coordinates courses on the methodology of clinical trials, statistics and the validity of diagnostics. Since 2002, Muriel Vray has been at the Pasteur Institute where she works on the development of clinical research in the field of infectious diseases with epidemiologists in the Pasteur Institute network and around the world. She has been involved with defining international guidelines on equivalence and non-inferiority trials, and is currently working on the methodology of trials and studies on therapeutic strategies. As an epidemiology researcher at INSERM (National Institute of Health and Medical Research), she specialized in clinical research and pharmacoepidemiology. Muriel Vray is an expert on clinical trial methodology.
0 kommentar(er)
